What happens if you are a slow Acetylator?
For instance, slow acetylators are more prone to develop a drug-induced systemic lupus erythematosus–like syndrome during prolonged therapy with procainamide or hydralazine, hematologic toxicity from dapsone, or polyneuropathy after isoniazid treatment.
For instance, slow acetylators are more prone to develop a drug-induced systemic lupus erythematosus–like syndrome during prolonged therapy with procainamide or hydralazine, hematologic toxicity from dapsone, or polyneuropathy after isoniazid treatment.
